POTASSIUM ACETATE injection solution

Country: Bandaríkin

Tungumál: enska

Heimild: NLM (National Library of Medicine)

Virkt innihaldsefni:

POTASSIUM ACETATE (UNII: M911911U02) (POTASSIUM CATION - UNII:295O53K152)

Fáanlegur frá:

American Regent, Inc.

INN (Alþjóðlegt nafn):

POTASSIUM ACETATE

Samsetning:

POTASSIUM ACETATE 196 mg in 1 mL

Gerð lyfseðils:

PRESCRIPTION DRUG

Leyfisstaða:

unapproved drug other

Vara einkenni

POTASSIUM ACETATE - POTASSIUM ACETATE INJECTION, SOLUTION
AMERICAN REGENT, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
POTASSIUM ACETATE INJECTION, USP, 2 MEQ/ML, 4 MOSMOL/ML
RX ONLY
100 mL PHARMACY BULK PACKAGE
NOT FOR DIRECT INFUSION
DESCRIPTION
Potassium Acetate Injection, USP, 2 mEq/mL, is a sterile, nonpyrogenic
solution of Potassium Acetate
(C H KO ) in Water for Injection. It must be diluted prior to
administration.
Each mL contains Potassium Acetate (Anhydrous) 196 mg (equivalent to 2
mEq/mL), Water for Injection
q.s. pH may be adjusted with Acetic Acid. Contains no bacteriostatic
agent or other preservatives.
CLINICAL PHARMACOLOGY
Potassium is found in low concentration in plasma and extracellular
fluids. It is the chief cation of body
cells, and is concerned with the maintenance of the body fluid
composition and electrolyte balance. The
major amount of potassium is excreted in the urine. Therefore, the
kidney normally determines
potassium balance.
The acetate ion is completely metabolized in the body, providing a
source of hydrogen ion acceptors.
INDICATIONS AND USAGE
Potassium Acetate Injection, USP, is indicated in the treatment of
potassium deficiency states when oral
replacement therapy is not feasible.
The solution is intended as an alternative to Potassium Chloride to
provide Potassium (K ) for addition
to large volume infusion fluids for intravenous use.
CONTRAINDICATIONS
Potassium Acetate Injection, USP, administration is contraindicated in
diseases where high potassium
levels may be encountered.
WARNINGS
Potassium Acetate Injection, USP, must be diluted before use. To avoid
potassium intoxication, infuse
potassium containing solutions slowly. Potassium replacement therapy
should be monitored whenever
possible by continuous or serial electrocardiography.
Solutions containing potassium ions should be used with great care, if
at all, in patie